- Additional Trial Required to Demonstrate Positive Effect on the Treatment of Ocular Symptoms in Dry Eye Disease
- Special Protocol Assessment Submitted on November 16, 2023 for Dry Eye Disease Chamber Crossover Clinical Trial
- Proposed Trial Top-Line Results and Potential NDA Resubmission Anticipated in First Half of 2024
- Cash Runway Extended into Late 2025
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.